Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets... Show more
RVTY is expected to report earnings to fall 3.39% to $1.14 per share on November 04
Q3'25
Est.
$1.14
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.06
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.15
The last earnings report on July 28 showed earnings per share of $1.18, beating the estimate of $1.14. With 733.87K shares outstanding, the current market capitalization sits at 9.96B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RVTY showed earnings on July 28, 2025. You can read more about the earnings report here.